Safety and Efficacy of First-Line Bevacizumab with Chemotherapy in Asian Patients with Advanced Nonsquamous NSCLC: Results from the Phase IV MO19390 (SAiL) Study

Chun-Ming Tsai1, Joseph Siu-kie Au2, Gee-Chen Chang3,4,5, Ashley Chi-kin Cheng6, Caicun Zhou7, Yi-long Wu8
1Section of Thoracic Oncology, Chest Department, Taipei Veterans General Hospital, Taipei, Taiwan
2Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
3Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan
4School of Medicine, China Medical University, Taichung, Taiwan
5Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
6Department of Oncology, Princess Margaret Hospital, Hong Kong, China
7Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
8Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

Tóm tắt

Từ khóa


Tài liệu tham khảo